tosyllysine chloromethyl ketone has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edsall, LC; Gelmann, EP; Kimura, K; Markowski, M; Spiegel, S | 1 |
Gelmann, EP; Kimura, K | 1 |
2 other study(ies) available for tosyllysine chloromethyl ketone and Cancer of Prostate
Article | Year |
---|---|
Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Ceramides; Drug Synergism; Enzyme Activation; Humans; Male; Prostatic Neoplasms; Serine Proteinase Inhibitors; Sphingomyelin Phosphodiesterase; Sphingosine; Tosyllysine Chloromethyl Ketone; Tumor Necrosis Factor-alpha | 2003 |
Tumor necrosis factor-alpha and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by gamma-irradiation.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Chloromethyl Ketones; Antigens, CD; Apoptosis; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Drug Synergism; Enzyme Activation; fas Receptor; Fas-Associated Death Domain Protein; Gamma Rays; Humans; Ligands; Male; Prostatic Neoplasms; Radiation Tolerance; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction; Tosyllysine Chloromethyl Ketone; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |